Abortion induced with methotrexate and misoprostol: A comparison of various protocols

Contraception

Volumn 55, Issue 3, 1997, Pages 159-163

  Wiebe, Ellen R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

medical abortion; methotrexate; misoprostol

Indexed keywords

METHOTREXATE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INDUCED ABORTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LIMB MALFORMATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ABORTIFACIENT AGENTS--ADMINISTRACTION AND DOSAGE; ABORTIFACIENT AGENTS--SIDE EFFECTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; AMERICAS; BIOLOGY; CANADA; COMPARATIVE STUDIES; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; MISOPROSTOL--ADMINISTRACTION AND DOSAGE; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; CANADA; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; METHOTREXATE; MISOPROSTOL; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TIME FACTORS; URBAN POPULATION;

EID: 0030936566     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00021-8     Document Type: Article

References (18)

1. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-48.
2. Creinin MD. Methotrexate for abortion at <42 days gestation. Contraception 1993;48:519-25.
3. Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs misoprostol alone for early abortion. JAMA 1994;272:1190-5.
4. Creinin MD. Methotrexate and misoprostol for abortion at 57-63 days gestation. Contraception 1994;50: 511-5.
5. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. Methotrexate and misoprostol for early abortion: a randomized trial comparing misoprostol 3 days and 7 days following methotrexate. Am J Obstet Gynecol 1995; 173:137-43.
6. Creinin MD, Park M. Acceptability of medical abortion with methotrexate and misoprostol. Contraception 1995;52:41-4.
7. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. New England J Med 1995;333: 337-40.
8. Schaff E, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:774-9.
9. Wiebe ER. Abortion induced with methotrexate and misoprostol. Can Med Assoc J 1996;154:165-70.
10. Schaff E, Eisinger SH, Franks P, Kim SS. Methotrexate and misoprostol for early abortion. Fam Med 1996;28: 196-9.
11. Schaff EA, Wortman M, Eisinger SH, Franks P. Methotrexate and misoprostol when surgical abortion fails. Obstet Gynecol 1996;87:450-2.
12. Milunsky A, Graef JW, Gaynor MF. Methotrexateinduced congenital malformations. J Pediatrics 1968; 72:790-5.
13. Powell HR, Ekert H. Methotrexate-induced congenital malformations. Med J Aust 1971;2:1076-7.
14. Ross GT. Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms. Cancer 1976;37:1043-7.
15. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of firsttrimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990;88: 589-92.
16. Gonzalez CH, Vargas FR, Perez AB, Kim CA, Brunoni D, Marques-Dias MJ. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64.
17. Schuler L, Ashton PW, Sanseverino MT. Teratogenicity of misoprostol. Lancet 1992;339:437.
18. Fonseca W, Alencar AJ, Mota FS, Coelho HL. Misoprostol and congenital malformations. Lancet 1991;338:56.